Krajina: Írsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
Medetomidine hydrochloride
Orion Corporation
QN05CM91
Medetomidine hydrochloride
1 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cats, Dogs
medetomidine
Neurological Preparations
Authorised
2010-03-12
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Domitor 1 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Medetomidine hydrochloride 1 mg/ml (equivalent to 0.85 mg/ml medetomidine) EXCIPIENTS: Methyl parahydroxybenzoate (E218) 1 mg/ml Propyl parahydroxybenzoate 0.2 mg/ml For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection Clear, colourless solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES DOGS: For restraint, sedation and analgesia associated with clinical examinations and procedures, minor surgery and as premedication before general anaesthesia In combination with butorphanol for sedation and analgesia CATS: For restraint and sedation In combination with ketamine for the induction of general anaesthesia prior to surgical procedures In combination with butorphanol for sedation and analgesia, and combined with both butorphanol and ketamine for general anaesthesia As a premedication before alfaxalone or alfadolone for general anaesthesia H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _8_ _/_ _0_ _4_ _/_ _2_ _0_ _1_ _7_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _4_ _1_ _2_ _3_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.3 CONTRAINDICATIONS Do not use in animals with cardiovascular disease, respiratory disease or impaired liver or kidney function, animals in shock, seriously debilitated animals, or Prečítajte si celý dokument